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Abstract: α-Herpesvirinae subfamily members, including herpes simplex virus type 1 (HSV-1) and bovine herpes virus 1 (BHV-1),
initiate infection in mucosal surfaces. BHV-1 and HSV-1 enter sensory neurons by cell-cell spread where a burst of viral gene expression occurs. When compared to non-neuronal cells, viral gene expression is quickly extinguished in sensory neurons resulting in neuronal survival and latency. The HSV-1 latency associated transcript (LAT), which is abundantly expressed in latently infected neurons,
inhibits apoptosis, viral transcription, and productive infection, and directly or indirectly enhances reactivation from latency in small
animal models. Three anti-apoptosis genes can be substituted for LAT, which will restore wild type levels of reactivation from latency
to a LAT null mutant virus. Two small non-coding RNAs encoded by LAT possess anti-apoptosis functions in transfected cells. The
BHV-1 latency related RNA (LR-RNA), like LAT, is abundantly expressed during latency. The LR-RNA encodes a protein (ORF2)
and two microRNAs that are expressed in certain latently infected neurons. Wild-type expression of LR gene products is required for
stress-induced reactivation from latency in cattle. ORF2 has anti-apoptosis functions and interacts with certain cellular transcription factors that stimulate viral transcription and productive infection. ORF2 is predicted to promote survival of infected neurons by inhibiting
apoptosis and sequestering cellular transcription factors which stimulate productive infection. In addition, the LR encoded microRNAs
inhibit viral transcription and apoptosis. In summary, the ability of BHV-1 and HSV-1 to interfere with apoptosis and productive infection in sensory neurons is crucial for the life-long latency-reactivation cycle in their respective hosts.
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α-Herpesvirinae Subfamily Members
are Important Pathogens in their
Respective Hosts

Herpes simplex virus type 1 (HSV-1) and bovine herpes
virus 1 (BHV-1) are both important pathogens in their
respective natural hosts and both are α-herpesvirinae
subfamily members. For example, HSV-1 is the
cause of one of the most frequent and serious viral
eye infections in the United States, with over 400,000
affected individuals.1 Following primary infection
of the eye, latency is established in sensory neurons
within trigeminal ganglia (TG).2,3 HSV-1 reactivates
sporadically from TG and the infectious virus can be
detected on surfaces of the eye, where it can cause
recurrent ocular disease. Reactivation from latency
is necessary for recurrent ocular HSV-1 infections.4,5
Long-term oral acyclovir treatment only reduces
ocular HSV-1 recurrences by 41%.6 Herpes simplex
virus type 2 (HSV-2) is the cause of the most common
sexually transmitted disease, and sporadic recurrent
genital lesions occur periodically. Two genital herpes
vaccine trials failed7,8 indicating there is a need for
new and effective therapies that will reduce the incidence of recurrent HSV-1 and HSV-2 disease.
Bovine herpes virus 1 (BHV-1) is an important
pathogen of cattle as it induces clinical signs in
the upper respiratory tract of cattle and is immunesuppressive. BHV-1 establishes latency in sensory
neurons, but periodically reactivates from latency,
and thus is widespread in cattle.2,9–11 BHV-1 infection inhibits cell-mediated immunity,12–15 CD8+
T cell recognition of infected cells,16–19 and induces
apoptosis in CD4+ T cells.20,21 Two viral regulatory proteins, bICP0 and bICP27, inhibit interferon
dependent transcription.10,22–25 Infection also erodes
mucosal surfaces of the upper respiratory tract,
which can allow bacterial pathogens to colonize the
lower respiratory tract.26–28

Acute Infection Results in High Levels
of Infectious Virus and Apoptosis

Binding and entry of HSV-1 and BHV-1 to mammalian cells are mediated by viral glycoproteins and cellular factors.29–31 A cellular receptor (HveA or HVEM)
is primarily expressed in activated T cells and belongs
to the tumor necrosis factor receptor family.32 Entry
of HSV-1 into epithelial and fibroblasts is mediated
2

by another membrane glycoprotein, HveB or HveC.33
HveC is an entry mediator for HSV-1 and BHV-1
and is abundantly expressed in neurons. Additionally,
soluble HveC blocks viral entry in neuronal-like cell
lines.33 After uncoating, the viral genome enters the
nucleus and productive infection is initiated.
HSV-1 and BHV-1 gene expression is tightly regulated in three distinct phases during productive infection of cultured cells: immediate early (IE), early (E),
or late (L).34 IE RNA expression does not require protein synthesis and is stimulated by VP16, a viral structural protein.35 E gene expression requires at least one
IE protein, and E genes encode nonstructural proteins
that stimulate viral DNA replication. L gene expression is maximal after viral DNA replication, requires
IE protein production, and L proteins comprise the
virion particle. Although a vigorous immune response
leads to viral clearance following primary infection,
BHV-1 and HSV-1 establish a life-long latent infection in ganglionic sensory neurons, primarily TG, or
sacral dorsal root ganglia.2,3,9,36 Approximately 40%
of sensory neurons appear to harbor viral genomes
during latency.37–41
Five HSV-1 IE genes encode ICP0, ICP4, ICP22,
ICP27, or ICP47. ICP442–45 and ICP2746–48 are
required for virus growth in tissue culture. ICP4
represses IE gene expression44,49–53 but activates E
or L gene expression by interacting with RNA polymerase II transcription factors and specifically binding viral DNA.49,54 ICP27 redistributes small nuclear
ribonucleoprotein complexes, interferes with splicing of IE transcripts, and promotes E and L poly A
site selection.55–58 ICP47 prevents transport of antigenic peptides into the endoplasmic reticulum59 and
inhibits CD8+ T cell responses.60 ICP22 enhances
viral gene expression, in part by modifying RNA
polymerase II.61 ICP0 increases steady-state levels
of viral mRNA and stimulates all viral promoters.62
ICP0 also binds several cellular proteins: (1) elongation factor 1-α63; (2) cyclin D364; (3) an ubiquitinspecific protease65,66; and (4) promyelocytic leukemia
(PML) protein.67–69 Interactions between ICP0 and
chromatin-remodeling enzymes activate viral transcription by multiple mechanisms, including sequestering histone deacetylase (HDAC) inhibitors.70,71
Secondly, HSV-1 ICP0 interacts with HDAC272 and
blocks histone deacetylation to stimulate viral gene
expression.73,74 ICP0 also alters a complex that inhibits
Journal of Cell Death 2013:6
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gene expression (REST/CoREST/HDAC repressor
complex).73 Since ICP0 can remove histones from
viral chromatin during productive infection,75 ICP0
may have similar functions during reactivation from
latency. These activities of ICP0 promote virus replication in differentiated cells.76 BHV-1 encoded ICP0
(bICP0) has similar functions as ICP0.10
Viral infection routinely leads to apoptosis in cultured cells.77–80 Killing of infected cells by apoptosis
in vivo can reduce inflammation, alter immune recognition, reduce burst size, and thus prevent virus spread.
Premature apoptosis of infected cells limits production
of infectious virus and limits viral spread. Members
of the α-herpesvirinae subfamily induce apoptosis
after infection of cultured cells.81–86 HSV-183,84,87–89 and
BHV-190 can also inhibit apoptosis in a cell type dependent manner after infection of cultured cells. HSV can
induce DNA damage, and consequently apoptosis,
even in the absence of productive infection.91–95 Two
viral proteins, US1.5 and UL13, activate caspase 3 in
the absence of other viral proteins, indicating these
viral proteins play an important role during virus
mediated apoptosis.96 Finally, ICP0 is also a trigger
for apoptosis in the context of productive infection, in
part because it activates viral gene expression.
HSV-1 encodes several proteins (ICP27, Us3,
Us5, gJ, gD, and LAT) that have anti-apoptosis
activity.83–85,87,88,97–105 Us3 is a serine/threonine protein
kinase that inhibits cleavage and activation of the

pro-apoptotic Bcl-2 family member, Bad. Us3 protein
expression in cultured cells, in the absence of other
viral proteins, inhibits caspase 3 activation, a crucial
executioner caspase that commits cells to apoptosis.
As expected, US3 inhibits the pro-apoptotic activity
of US1.5 and UL13 by blocking caspase 3 activation.96
These anti-apoptotic genes play an important role in
the pathogenic properties of HSV-1.

Viral Genes Expressed During
Latency Regulate the LatencyReactivation Cycle
The HSV-1 latency associated transcript is
abundantly expressed during latency and
regulates the latency-reactivation cycle

The HSV-1 latency associated transcript (LAT) is
abundantly expressed in sensory gangionic neurons of
mice, rabbits, or humans that are latently infected.106–114
LAT is predominantly expressed in the nucleus
of latently infected neurons suggesting it is a nonprotein coding regulatory RNA. LAT is antisense to
ICP0 and overlaps ICP0 mRNA sequences (Fig. 1B),
suggesting LAT inhibits ICP0 expression by an antisense mechanism. Although the ability of LAT to
repress ICP0 expression may be important, LAT
sequences that promote spontaneous reactivation
in a rabbit ocular model of infection do not overlap
ICP0 mRNA sequences.115
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Figure 1. Location of genes within the HSV-1 repeats. (Panel A) UL and US denote the unique sequences of the long (L) and short (S) components of the
genome. The boxes depict repeat sequences. (Panel B) Transcription map of the repeat region. Location and orientation of LAT,111,112 ICP0, α134.5,253,254
ORFP,150 L/STs255 are indicated by solid lines.
Note: Partially mapped transcripts (αX and αX) are denoted by dashed arrows.256,257
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Splicing of the 8.5 kb LAT transcript yields
a stable 2 kb LAT and an unstable 6.5 kb LAT
(Fig. 1B).107,111,116 Correct splicing of the 2 kb LAT
is necessary for establishment and maintenance of
latency.117,118 In general, the 2 kb LAT is not capped,
is poly A-, appears to be circular, and is a stable
intron.119,120 A subset of LAT is detected in the cytoplasm97,121,122 and is associated with polyribosomes
or splicing factors.97,123 Small non-coding RNAs can
regulate gene expression,124,125 promote neuronal differentiation,126 or inhibit apoptosis127 suggesting LAT
is a non-coding regulatory RNA.
A study by Umbach et al128 concluded that LAT
is a microRNA (miRNA) precursor which encodes
four miRNAs, two within LAT promoter sequences
(Fig. 2A and B). LAT miR-H6, reduces ICP4 protein

steady state levels but not ICP4 RNA levels. Protein
levels, not RNA levels, of ICP0 are inhibited by the
LAT miRNA, miR-H2-3p. Within the first 1.5 kb
of LAT coding sequences, two small RNAs (sRNAs),
LAT sRNA1 and sRNA2, were identified (Fig. 2B).
The sRNAs are larger than mature miRNAs (typically
23 nucleotides long) and the sequence of both possess extensive secondary structure. The sRNAs can
be detected in TG of mice latently infected with wildtype HSV-1, but not in TG of mice latently infected
with a LAT null mutant.79,129 LAT sRNA2, but not
LAT sRNA1, reduced ICP4 protein levels in transient
transfection assays. Both LAT sRNAs inhibit productive infection in mouse neuroblastoma cells, however
LAT sRNA1 inhibited productive infection more
efficiently than LAT sRNA2.130 Collectively, these
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Figure 2. Schematic of putative factors encoded within the LAT locus. (Panel A) Schematic of genes within the long repeats that contain the LAT locus.
The large arrow indicates the primary LAT transcript. The solid rectangle represents the sTable 2 kb LAT intron. Initiation of LAT transcription is denoted
by the arrow at +1 (genomic nucleotide 118801). Several restriction enzyme sites and the relative locations of the ICP0 and ICP34.5 transcripts are
shown for reference. The location of the 6 microRNAs (miR-H1-6) that is located within the 8.5 kb LAT128 are shown. (Panel B) Partial restriction map
of LAT and position of LAT open reading frames (L1-8) within the first 1.5 Kb of strain McKrae LAT coding sequences, which were based on previous
studies.148 The numbering system of the ORFs was consistent with a previous study.148 Only the ORFs with at least 30 amino acids are shown (the
number of amino acids in each ORF is denoted by the numbers in brackets). Open circles denote the position of two LAT small RNAs that are encoded
within the first 1.5 kb LAT coding sequences.258 Positions of UOL transcript, AL transcript, and ORFs located on the opposite strand of LAT (AL2 and
AL3) are shown. The number of amino acids of AL2 and AL3 are in brackets. Nucleotide positions relative to the start of LAT transcription are not shown
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studies provide evidence that the LAT encoded miRNAs and sRNAs promote latency by interfering with
expression of important viral transcriptional regulatory proteins.
The LAT locus encodes additional transcripts
(Fig. 2B). More than one transcript, including UOL
(Upstream of LAT)131 are located within LAT promoter sequences. Expression of the UOL transcript
or protein does not reduce reactivation from latency
in rabbits.132 An antisense to LAT (AL) transcript
is expressed from the first 1.5 kb of LAT coding
sequences and appears to encode a protein.133 Two
additional small open reading frames (ORFs) that are
antisense to LAT (AL2 and AL3) are present in LAT
coding sequences. An AL3 transcript is expressed
during productive infection and in TG of mice latently
infected with wild-type HSV-1, but not a LAT null
mutant virus.134 An AL3-specific polyclonal antibody
detected a protein in a subset of TG neurons in latently
infected mice. A transcript encompassing AL2 has not
been detected during productive infection or latency
(unpublished data).
LAT null HSV-1 mutants have been examined
in various small animal models.2,3 Although two
studies concluded that LAT does not play a role in
latency,135,136 most have provided evidence that LAT
is important. This discrepancy may be due to the
strain of virus or mouse that was used for specific
studies. LAT enhances the establishment of latency
in mice137,138 and in rabbit ocular infection models,139
in part by reducing lytic cycle viral gene expression in
TG of mice.140,141 By enhancing the establishment
of latency, LAT would increase the pool of latently
infected neurons; thus indirectly increasing the incidence of reactivation from latency.
As a result of stress or other external stimuli, reactivation from latency can occur, resulting in virus
shedding (Fig. 4). The McKrae strain of wild-type
HSV-1, however not a LAT null mutant, is consistently
detected in tears of infected rabbits, due to spontaneous reactivation.139,142–145 These same LAT null mutants
grow with wild-type efficiency in cultured cells and
in acutely infected rabbits. When just the first 1.5 kb
of LAT coding sequences (Fig. 2B) is expressed from
the HSV-1 genome, wild-type levels of spontaneous reactivation from latency occur in rabbits.139
Similar results were observed using another virulent
strain of HSV-1 (17 syn+) in a rabbit eye model.146,147
Journal of Cell Death 2013:6

The first 1.5 kb of LAT coding sequences does not
overlap ICP0, suggesting that antisense repression of
ICP0 expression by LAT is not important for spontaneous reactivation in the rabbit ocular model of infection. The factors encoded by the first 1.5 kb of LAT
coding sequences that promote spontaneous reactivation have not been fully characterized.
Although certain studies suggested LAT does not
encode a protein,148 other studies have concluded
that a protein encoded within LAT sequences is
expressed.131,149–154 These proteins were suggested to
either substitute for ICP0 functions,153,154 interfere
with binding of ICP4 to DNA,152 or their functions
were not described. The proposed LAT proteins are
mapped downstream of the critical first 1.5 kb of the
primary LAT transcript, a region that appears both
sufficient and necessary for the wild type spontaneous reactivation phenotype in rabbit models.139,155
Within the first 1.5 kb of LAT coding sequences,
8 potential ORFs have been identified in the McKrae
strain (Fig. 2B).148 The L2 ORF (Fig. 2B) appears
to be expressed in TG of latently infected mice.156
Although LAT is not absolutely required for the
latency-reactivation cycle in small animal models,
its importance may be underestimated using small
animal models and measuring latency in terms of
weeks or months, not decades.

The BHV-1 latency related RNA
is abundantly expressed in sensory
neurons and is necessary for
reactivation from latency

Latency related (LR) RNA is abundantly expressed in
TG neurons of calves that are latently infected.111,157
Two different start sites of LR-RNA transcription
(Fig. 3A) have been identifed suggesting this has
functional significane. It is clear that the LR gene
encodes more than one product.11,36 For example, the
LR gene contains two-well defined ORFs (ORF2 and
ORF1; Fig. 3B) and two reading frames that lack an
initiating methionine (RF-B and RF-C). As a result
of alternative splicing of polyA+ LR-RNA in TG of
infected calves (Fig. 3A),158,159 ORF2 can be fused
with ORF1 protein coding sequences or RF-B. The
ORF2/ORF1 fusion protein stably interacts with the
cellular transcription factor C/EBP-alpha.160 C/EBPalpha RNA and protein levels increase in TG neurons
5
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Figure 3. Schematic of the BHV-1 LR gene and surrounding genes.
(Panel A) The start sites for LR transcription during latency and productive
infection were previously described.159,259 (Panel B) Organization of LR
ORFs and 3′ terminus of bICP0. ORF-1 and ORF-2 are located in the LR
gene and have the potential to encode a 40 or 25 kd protein respectively.
Notes: Reading Frames B (RF-B) and C (RF-C) are open reading frames
that lack an initiating Met. The (*) denotes the position of stop codons that
are in frame with the respective ORF. The positions of ORF-E and bICP0,
which are antisense to LR-RNA, are also shown.

during dexamethasone induced reactivation from
latency. Over-expression of C/EBP-alpha enhanced
productive infection,161 suggesting that ORF2 sequesters C/EBP-alpha and reduces the efficieny of productive infection during the latency-reactivation cycle.
One day after calves are infected and during
latency, splicing of LR-RNA in TG is such that ORF2
is intact,159 suggesting ORF2 expression is important
for the latency-reactivation cycle. ORF2 interacts

with Notch1 and Notch3, components of the Notch
signaling pathway.162 Mammalian Notch receptor
family members (Notch1-4) are membrane tethered
transcription factors that regulate many developmental and physiological processes.163,164 For example,
Notch promotes neuronal maintenance, development,
and differentiation.165–167 Notch3168 and Notch1169,170
promote cell survival by activating a protein kinase,
(AKT) which inhibits apoptosis. Notch family members can also induce apoptosis,163,164 suggesting
Notch influences cell survival by cell-type dependent
mechanisms. When the Notch receptor is engaged
by one of its five transmembrane ligands (Jagged1,
Jagged2, Delta-like1, Delta-like3, or Delta-like4),
the Notch intracellular domain (ICD) is cleaved by
specific proteases, and subsequently translocates
to the nucleus. In the nucelus, Notch ICD interacts with members of the CSL family of transcriptional factors, CBF1, Su(H), or Lag1 (also referred
to as RBP-J binding proteins) subsequently activating downstream genes. Notch1, but not Notch3,
enhances BHV-1 productive infection163 and Notch1
activates the BHV-1 immediate-early transcription
unit 1 (IEtu1) and bICP0 early promoters. Notch1 and
Notch3 trans-activated the late glycoprotein C (gC)

Acute infection

(High levels of infectious virus)

Establishment of latency

Suppression of viral gene expression
suppression of viral replication
LAT or LR gene expression
neuronal survival

Maintenance of latency
LAT or LR gene expression
neuronal survival
(Years-Decades)
Stress (increased corticosteroids)

Reactivation from latency
Reduced LAT or LR gene expression
Increased lytic cycle viral gene expression

Most neurons
re-establish latency

Small subset of neurons
shed infectious virus

Figure 4. Putative steps that occur during the latency-reactivation cycle.
Note: For details, see text.
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promoter. ORF2 interferes with the ability of Notch1
to trans-activate the bICP0 early promoter and Notch1
or Notch3 mediated activation of the gC promoter162
suggesting this function is important for establishing and/or maintaining latency. Notch3 RNA levels
are higher during dexamethasone (DEX) induced
reactivation from latency, suggesting Notch family
members stimulate productive infection during reactivation from latency. Activation of Notch signaling
in post-mitotic-neurons or neuroblastoma cells inhibits neurite sprouting165,171–174 and axon repair,175 which
can lead to neuronal degeneration and apoptosis.176–178
Conversely, neurite sprouting correlates with regeneration of damaged axons and dendrites.175 ORF2
promotes neuruite sprouting and neuronal differentiation of mouse neuroblastoma cells when Notch1 or
Notch3 is over-expressed.179 Collectively, these studies suggest that ORF2 interactions with Notch family
members promote the establishment and maintenace
of latency by (1) interfering with viral gene expression necessary for productive infection, (2) supporting a mature neuronal phenotype, and (3) overcoming
the deleterious effects of Notch expression during
stress-induced reactivation from latency.
Although the results from the LR mutant virus suggested that proteins encoded by the LR gene are necessary for the latency-reactivation cycle, non-protein
coding functions within LR-RNA have also been
identified. For example, the intact LR gene inhibits
the ability of bICP0 to stimulate productive infection
in a dose-dependent manner.180,181 Insertion of three
in-frame stop codons at the amino-terminus of the
first ORF within the LR gene (ORF2) inhibited bICP0
repression with similar efficiency as the wild-type LR
gene, suggesting expression of a LR protein is not
required.181 LR gene products also inhibit mammalian
cell growth,182,183 and the cell growth inhibitory function of the LR gene maps to a 463-bp fragment that
lacks a significant open reading frame.182 Two miRNAs located upstream of ORF2 are expressed during
latency.184 These miRNAs, or larger sRNAs containing these miRNAs, reduced bICP0 protein levels in
transient transfection assays.
A small ORF located within the LR promoter is
designated ORF-E (Fig. 3B). ORF-E is antisense to
the LR transcript and is downstream of bICP0 coding
sequences, but does not overlap bICP0. A transcript

Journal of Cell Death 2013:6

that encompasses ORF-E is expressed during productive infection and in TG of latently infected calves.185
The LR promoter contains multiple cis-acting motifs,
has a neuronal specific binding domain,186–188 and
contains a long AT-rich motif (40/53 nucleotides are
A or T) that may promote ORF-E transcription. When
ORF-E protein coding sequences are fused in frame
with green fluorescent protein (GFP) sequences, GFP
protein expression is detected in the nucleus of mouse
or human neuroblastoma cells. In contrast, the ORFE-GFP fusion protein is detected throughout rabbit
skin cells. In transient transfection assays, ORF-E
promotes neurite formation in mouse neuroblastoma
cells,189 which may support a mature neuronal phenotype following infection.

LAT and LR Gene Products Inhibit
Apoptosis
LAT inhibits apoptosis

LAT expressing plasmids interfere with apoptosis
in transiently transfected cells, and LAT expressing
viruses inhibit apoptosis in TG of infected mice or
rabbits.117,190–192 The anti-apoptotic functions of LAT
correlate with promoting spontaneous reactivation
from latency.191,193 In the context of promoting spontaneous reactivation from latency in the rabbit model
(model), inhibiting apoptosis is the most important
function of LAT as three different anti-apoptosis
genes129,194–196 restore wild-type levels of spontaneous
reactivation from latency to a LAT null mutant. LAT
may encode other functions because the LAT null
mutants that express cellular anti-apoptosis genes
have reduced virulence, in spite of reactivating from
latency with wild-type frequency. LAT expressing
plasmids, in the absence of other viral genes, inhibit
caspase 8- and caspase 9-induced apoptosis,193,197 the
two major apoptotic pathways in mammals.198–200 LAT
also inhibits caspase 3 activation.201
LAT sRNA1 and sRNA2 cooperate to inhibit coldshock induced apoptosis in mouse neuroblastoma
cells.130 Introduction of ATGTTG mutations in
ORFs within the first 1.5 kb of LAT coding sequences
impairs the anti-apoptotic functions of LAT,202 suggesting that LAT either encodes a functional protein or
alters RNA structure. Two of these ATGTTG mutations are within LAT sRNA1 and sRNA2, and introducing these mutations into the small RNAs inhibits
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their ability to inhibit apoptosis.130 At this time, it is
not clear how these sRNAs interfere with apoptosis.
It will also be important to construct a recombinant
virus with these same mutations and test whether the
spontaneous reactivation incidence is affected.
LAT also inhibits GrzB induced apoptosis in
transient transfection studies.203 GrzB is released
from CD8+ T cells as well as other specific lymphocytes; GrzB has features similar to apical caspases,
and can induce apoptosis in most cell types.204–207
Inhibiting GrzB induced apoptosis may be important for the latency-reactivation cycle because CD8+
T lymphocytes control HSV infection in sensory
ganglia.208,209

The LR gene encodes more than one
product that inhibits apoptosis

A mutant BHV-1 strain with 3 stop codons after the
initiating methionine codon of ORF-2 (LR mutant
virus) does not express detectable levels of ORF-2101
but expresses reduced levels of ORF1 in cultured
cells during productive infection.210 The LR mutant
virus grows less efficiently in the ocular cavity and
TG, but grows almost as efficiently as wild-type
BHV-1 in the nasal cavity, and does not reactivate
from latency following DEX treatment.211,212 The
LR mutant virus induces higher levels of apoptosis
in TG neurons of infected calves,213 and a LR gene
expressing plasmid with the same stop codon mutations does not effectively inhibit apoptosis.214,215
ORF2 expression in the absence of other viral
genes inhibits apoptosis in transiently transfected
cells,216,217 suggesting that ORF2 is a dominant function encoded by the LR gene. ORF2, like LAT, can
inhibit caspase 8 and caspase 9 mediated apoptosis;
however the mechanism by which it inhibits apoptosis is not known.
Two microRNAs encoded within the LR gene
(Fig. 3A) interfere with bICP0 protein expression184
and cold shock induced apoptosis in transfected
mouse neuroblastoma cells (Neuro-2A cells).218 Since
cold shock induced apoptosis in Neuro-2A cells is
inhibited by casapse 3 and caspase 9 inhibitors,219
the microRNAs must influence these apoptotic signaling pathways. The ability of the microRNAs to
stimulate the anti-apoptotic transcription factor
NF-αB220–223 seems to be important for inhibiting
cold-shock induced apoptosis. In summary, these
8

results provide additional evidence that interfering
with apoptosis is crucial for a successful life-long
latent infection.

Why is Inhibiting Neuronal Apoptosis
Important During the LatencyReactivation Cycle?

The latency-reactivation cycle has been operationally divided into three distinct steps: establishment,
maintenance, and reactivation (Fig. 4). Following
acute infection where high levels of infectious virus
are produced, virus particles enter sensory neurons.
Initial entry of the viral genome into a sensory neuron results in a burst of lytic cycle viral gene expression and infectious viruses are produced. Viral gene
expression is then extinguished, with the exception of HSV-1 LAT and BHV-1 LR gene products.
Neuronal cell factors,2,9 LAT encoded microRNAs
plus sRNAs,128,130 and LR encoded functions162,184
interfere with various aspects of productive infection.
During acute infection and establishment of latency,
neuronal and satellite cells undergo apoptosis when
small animal models are infected with HSV-2224 or
HSV-1.225–227 BHV-1 replication and gene expression also occur in TG of acutely infected calves,
resulting in apoptosis of neurons and non-neuronal
cells.192,213,228
HSV-1 LAT192 and the LR gene213 enhance neuronal
survival during the establishment of latency. The ability
of LAT229 and the LR gene179 to promote a mature neuronal phenotype and sprout neurites may also promote
establishment of latency by stimulating repair of damaged neurons following infection. Successful establishment correlates with an increase in the number of
infected neurons that survive and enhances the probability that reactivation from latency occurs.
Maintenance of latency is a phase that lasts for the
duration of the host’s life and is operationally defined
as a period when infectious virus is not readily
detected. In general, abundant expression of viral
genes required for productive infection does not occur.
LAT or LR gene products are abundantly expressed
during the maintenance of latency. Expression of LAT
correlates with an increase of latently infected neurons during the maintenance of latency,230 suggesting
latently infected sensory neurons are exposed to apoptotic stimuli during the maintenance of latency. It is
reasonable to predict that LAT and LR gene products
Journal of Cell Death 2013:6
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actively participate in maintaining a latent infection
in sensory neurons.
Reactivation from latency is initiated by external
stimuli (stress, immunosuppression, or UV light for
example), which ultimately must stimulate viral gene
expression.36,231,232 Abundant viral gene expression
can be detected in sensory neurons and infectious
virus can be isolated from TG, ocular swabs, and/or
nasal swabs. Stress leads to elevated corticosteriod
levels, which has rapid effects on neural activity.233,234
DEX, a synthetic corticosteriod, induces viral gene
expression,235 stimulates an HSV-1 origin of replication (Ori-L) in neuronal cells,55 and alters splicing patterns in the absence of protein synthesis.236 DEX and
other apoptosis stimulators can also stimulate HSV-1
reactivation from latency.237,238 BHV-1 reactivation
from latency is induced by DEX, in part because it
stimulates expression of cellular transcription factors
and viral gene expression while repressing expression
of LR gene products.9,11,36 Prolonged exposure to corticosteroids can also induce immunosuppression, in
part by inducing apoptosis in lymphocytes.239 A subset
of neurons that successfully reactivate from latency
to produce infectious virus may not survive;240–242
however it is not clear if this is the fate for all neurons that produce infectious virus during reactivation
from latency. Most latently infected neurons that are
exposed to reactivation stimuli re-establish latency
and do not produce infectious virus.243,244 Given that
sensory neurons are terminally differentiated cells,
inhibiting apoptosis during the latency-reactivation
cycle is crucial for life-long latent infections of
α-herpesvirinae subfamily members.
Numerous studies have demonstrated that
infiltrating lymphocytes in TG regulate the
latency-reactivation cycle. For example, a persistent
cell-mediated immune response occurs in TG during
latency and CD8+ T lymphocytes inhibit reactivation
from latency.208,209,245–250 Release of granzyme B from
CD8+ T cells into latently infected neurons helps to
inhibit reactivation from latency by cleaving the viral
transcriptional trans-activator, ICP4.251 Since it is well
established that granzyme B activates caspase 3 and
the intrinsic pathway of apoptosis,207 the ability of LAT
and perhaps LR gene products to inhibit apoptosis is
important to overcome the effects of granzyme B.
The ability of HSV-1 to inhibit major histocompatibility complex (MHC) class I presentation in sensory
Journal of Cell Death 2013:6

neurons correlates with successful reactivation252
providing further evidence that CD8+ T cells monitor
latently infected neurons. In conclusion, the ability of
HSV-1, HSV-2, and BHV-1 to reactivate from latency
is regulated by complex virus-host interactions.

Perspectives

Although genetic and functional studies have demonstrated that LAT and the LR gene regulate the
latency-reactivation cycle, there are many unanswered
questions. For example, identifying the functions of
various transcripts, the small non-coding RNAs, and the
ORFs within LAT are crucial to understand the role these
various factors play in the latency-reactivation cycle. It
would not be surprising to find that one or more of these
factors encoded within the LAT locus regulate certain
neuronal specific functions that maintain normal functions. It will be difficult to make additional LAT mutant
viruses as many of these factors overlap and deletion of
these sequences would likely interfere with expression
of more than one LAT encoded factor. Consequently,
many of these studies will have to be performed in transient transfection assays in primary neurons or neuroblastoma cells. Finally, examining LAT in small animal
models in terms of weeks after acute infection may not
accurately reflect the latency-reactivation cycle in the
context of life-long latency in humans.
With respect to the LR gene, there are no studies that
have determined whether ORF1, ORF-E, or the microRNAs play a role in the latency-reactivation cycle. Furthermore, functional analysis of ORF-1 and ORF-E has not
been performed. Identifying the cellular proteins that interact with ORF-1 and ORF-E may provide insight into their
functions. In summary, the finding that sequences encompassing LAT and the LR gene encode for more than one
transcript and/or small non-coding RNAs implies many
functions are necessary to successfully regulate the lifelong latency-reactivation in the natural host.
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